Logo image of DLXY

DELIXY HOLDINGS LTD (DLXY) Stock Fundamental Analysis

USA - NASDAQ:DLXY - KYG2703G1038 - Common Stock

1.13 USD
-5.59 (-83.18%)
Last: 9/30/2025, 8:00:01 PM
0.9695 USD
-0.16 (-14.2%)
Pre-Market: 10/1/2025, 7:28:39 AM
Fundamental Rating

3

Taking everything into account, DLXY scores 3 out of 10 in our fundamental rating. DLXY was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. DLXY has an average financial health and profitability rating. DLXY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year DLXY was profitable.
DLXY had a positive operating cash flow in the past year.
DLXY Yearly Net Income VS EBIT VS OCF VS FCFDLXY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 5M -5M

1.2 Ratios

With a decent Return On Assets value of 5.97%, DLXY is doing good in the industry, outperforming 66.82% of the companies in the same industry.
With an excellent Return On Equity value of 104.36%, DLXY belongs to the best of the industry, outperforming 96.68% of the companies in the same industry.
With an excellent Return On Invested Capital value of 19.87%, DLXY belongs to the best of the industry, outperforming 96.21% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DLXY is significantly above the industry average of 21.71%.
The last Return On Invested Capital (19.87%) for DLXY is well below the 3 year average (43.14%), which needs to be investigated, but indicates that DLXY had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.97%
ROE 104.36%
ROIC 19.87%
ROA(3y)10.72%
ROA(5y)N/A
ROE(3y)78.29%
ROE(5y)N/A
ROIC(3y)43.14%
ROIC(5y)N/A
DLXY Yearly ROA, ROE, ROICDLXY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 20 40 60 80 100

1.3 Margins

Looking at the Profit Margin, with a value of 0.22%, DLXY is doing worse than 67.30% of the companies in the same industry.
DLXY's Operating Margin of 0.23% is on the low side compared to the rest of the industry. DLXY is outperformed by 75.36% of its industry peers.
DLXY has a Gross Margin of 0.68%. This is in the lower half of the industry: DLXY underperforms 78.20% of its industry peers.
Industry RankSector Rank
OM 0.23%
PM (TTM) 0.22%
GM 0.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DLXY Yearly Profit, Operating, Gross MarginsDLXY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0.2 0.4 0.6

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DLXY is creating value.
Compared to 1 year ago, DLXY has about the same amount of shares outstanding.
DLXY has a worse debt/assets ratio than last year.
DLXY Yearly Shares OutstandingDLXY Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M
DLXY Yearly Total Debt VS Total AssetsDLXY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

DLXY has an Altman-Z score of 27.62. This indicates that DLXY is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 27.62, DLXY belongs to the top of the industry, outperforming 96.68% of the companies in the same industry.
DLXY has a debt to FCF ratio of 4.08. This is a neutral value as DLXY would need 4.08 years to pay back of all of its debts.
DLXY has a better Debt to FCF ratio (4.08) than 71.56% of its industry peers.
DLXY has a Debt/Equity ratio of 3.70. This is a high value indicating a heavy dependency on external financing.
DLXY has a worse Debt to Equity ratio (3.70) than 86.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.7
Debt/FCF 4.08
Altman-Z 27.62
ROIC/WACC2.52
WACC7.9%
DLXY Yearly LT Debt VS Equity VS FCFDLXY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

DLXY has a Current Ratio of 1.29. This is a normal value and indicates that DLXY is financially healthy and should not expect problems in meeting its short term obligations.
DLXY's Current ratio of 1.29 is fine compared to the rest of the industry. DLXY outperforms 60.19% of its industry peers.
DLXY has a Quick Ratio of 1.29. This is a normal value and indicates that DLXY is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.29, DLXY is in the better half of the industry, outperforming 66.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
DLXY Yearly Current Assets VS Current LiabilitesDLXY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for DLXY have decreased strongly by -95.92% in the last year.
Looking at the last year, DLXY shows a quite strong growth in Revenue. The Revenue has grown by 8.90% in the last year.
EPS 1Y (TTM)-95.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-95.91%
Revenue 1Y (TTM)8.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DLXY Yearly Revenue VS EstimatesDLXY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 200M 400M 600M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.56, which indicates a correct valuation of DLXY.
DLXY's Price/Earnings ratio is a bit cheaper when compared to the industry. DLXY is cheaper than 63.51% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.76. DLXY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.56
Fwd PE N/A
DLXY Price Earnings VS Forward Price EarningsDLXY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DLXY indicates a slightly more expensive valuation: DLXY is more expensive than 61.14% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, DLXY is valued a bit cheaper than the industry average as 62.56% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.09
EV/EBITDA 13.16
DLXY Per share dataDLXY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DLXY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DELIXY HOLDINGS LTD

NASDAQ:DLXY (9/30/2025, 8:00:01 PM)

Premarket: 0.9695 -0.16 (-14.2%)

1.13

-5.59 (-83.18%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.04%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.48M
AnalystsN/A
Price TargetN/A
Short Float %0.37%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.56
Fwd PE N/A
P/S 0.03
P/FCF 15.09
P/OCF 15.09
P/B 13.66
P/tB 13.66
EV/EBITDA 13.16
EPS(TTM)0.09
EY7.96%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.07
FCFY6.62%
OCF(TTM)0.07
OCFY6.62%
SpS38.52
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.97%
ROE 104.36%
ROCE 22.95%
ROIC 19.87%
ROICexc 41.81%
ROICexgc 41.81%
OM 0.23%
PM (TTM) 0.22%
GM 0.68%
FCFM 0.19%
ROA(3y)10.72%
ROA(5y)N/A
ROE(3y)78.29%
ROE(5y)N/A
ROIC(3y)43.14%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)49.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover26.62
Health
Industry RankSector Rank
Debt/Equity 3.7
Debt/FCF 4.08
Debt/EBITDA 3.27
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 487.33
Cash Conversion 80%
Profit Quality 86.69%
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z 27.62
F-Score3
WACC7.9%
ROIC/WACC2.52
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-95.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-95.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.98%
OCF growth 3YN/A
OCF growth 5YN/A